Patents by Inventor Michael Baratta

Michael Baratta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230263972
    Abstract: Various exemplary drug delivery devices with on-board drug destruction, drug products utilizing the same, and methods of using drug delivery devices with on-board drug destruction are provided. In general, a nasal drug delivery device configured to dispense a drug therefrom into a nose includes a destruction mechanism configured to destroy drug contained in the drug delivery device. The destruction mechanism can be configured to destroy the drug before a first actuation of the drug delivery device to deliver the drug therefrom such that the destruction mechanism destroys substantially all of the drug contained in the drug delivery device. Alternatively or in addition, the destruction mechanism can be configured to destroy the drug after a first actuation of the drug delivery device to deliver the drug therefrom such that the destruction mechanism destroys substantially all of the drug remaining in the drug delivery device.
    Type: Application
    Filed: September 1, 2021
    Publication date: August 24, 2023
    Inventors: Emma Louise HUBERT, Monica A. KAPIL, MingQi ZHAO, Steven M. VESOLE, Ian SCRIMGEOUR, David RAMOS, Jaskaran SINGH, Jingli WANG, David KALIKHMAN, Shagun POPLI, Peter KRULEVITCH, Hong YAN, Michael A. BARATTA, Whitney PHILLIPS, Francesco N. ALBERTINI, Michael CANNAMELA
  • Publication number: 20220409127
    Abstract: In general, methods, systems, and devices for remote aggregation of data for drug administration devices are provided. In one exemplary embodiment, data indicative of information sensed with a sensor of a drug administration device can be wirelessly transmitted from a drug administration device to a server. The server can use the data to correlate the patients use of the drug with the patients clinical outcome, perform a cost analysis of the patients treatment, determine whether the drug was delivered to the patient in compliance with the patients treatment plan, identify a malfunction in the administration of the drug, determine that additional data is needed from the drug administration device and trigger a request for the additional data to be wirelessly transmitted from the server to the drug administration device, and/or predictively model the patients clinical outcome.
    Type: Application
    Filed: September 24, 2020
    Publication date: December 29, 2022
    Inventors: Francesco N. ALBERTINI, Michael A. BARATTA, Jason L. HARRIS, Emma Louise HUBERT, Michael HUTCHINSON, David KALIKHMAN, Monica A. KAPIL, Peter KRULEVITCH, Shagun POPLI, Frederick E. Shelton, IV, Jaskaran SINGH, Jingli WANG
  • Publication number: 20220336074
    Abstract: In general, interconnection of drug administration systems is provided. In an exemplary embodiment, a drug administration device and a remotely located server can establish a unique key for wireless communication between the device and the server. The drug administration device can be configured to sense information relating to at least one of the device and a drug and can be configured to anonymize data indicative of the sensed information using the key stored in memory of the device. The drug administration device can also be configured to use the key in decrypting data received from the server.
    Type: Application
    Filed: September 24, 2020
    Publication date: October 20, 2022
    Inventors: Gregory J. BAKOS, Michael A. BARATTA, Yueheng DOU, Jason L. HARRIS, Emma Louise HUBERT, Monica A. KAPIL, Peter KRULEVITCH, Wouter Jacques Noel LEQUIEU, Dolores PEREZ, Whitney PHILLIPS, Frederick E. SHELTON, Hong YAN
  • Patent number: 11381061
    Abstract: A system for servicing cable includes a field-end assembly and a live-end assembly, each mounted on a support structure having at least one drive mechanism operable to cause relative linear movement between the field-end assembly and the live-end assembly. A drilling-and-shorting assembly can create a short circuit in a field-end of the cable, and a continuity tester can test the integrity of the short-circuit. The field end of the cable can then be ejected from the system, and an end-cap-cradle assembly can position an end cap on a live end of an electrical cable and test its installation.
    Type: Grant
    Filed: December 16, 2019
    Date of Patent: July 5, 2022
    Assignees: ULC Technologies, LLC, Consolidated Edison Company of New York, Inc.
    Inventors: Alex Symington, Dennis John Semet, Caner Oktayer, Aalap Rajendra Shah, Than Lin Htaik, Patrick McHugh, Maggie Chow, George Murray, Luis Jerez, Thomas Campbell, Michael Baratta
  • Publication number: 20200194978
    Abstract: A system for servicing cable includes a field-end assembly and a live-end assembly, each mounted on a support structure having at least one drive mechanism operable to cause relative linear movement between the field-end assembly and the live-end assembly. A drilling-and-shorting assembly can create a short circuit in a field-end of the cable, and a continuity tester can test the integrity of the short-circuit. The field end of the cable can then be ejected from the system, and an end-cap-cradle assembly can position an end cap on a live end of an electrical cable and test its installation.
    Type: Application
    Filed: December 16, 2019
    Publication date: June 18, 2020
    Inventors: Alex SYMINGTON, Dennis John SEMET, Caner OKTAYER, Aalap Rajendra SHAH, Than Lin HTAIK, Patrick McHUGH, Maggie CHOW, George MURRAY, Luis JEREZ, Thomas CAMPBELL, Michael BARATTA
  • Patent number: 8910638
    Abstract: In exemplary implementations of this invention, high-throughput screening of a mammalian brain is performed to locate neural circuit targets of interest. A variety of search patterns may be used for this neural screening, including (a) iterative subdivision, (b) serial search, and (c) combinatorial. To perform this neural screening, an array of optical fibers (or an array of waveguides) is inserted into the brain. Alternately, the array is positioned adjacent to the brain. Each fiber or waveguide in the array is coupled to a light source (LED or laser). The brain has been previously sensitized to light, using genetically encoded optical neural control reagents, which are delivered either using viruses or via transgenic means. In the screening, the array is used to optically perturb the brain. For example, the neurons of the brain may be activated by one color of light, and/or silenced by another color of light.
    Type: Grant
    Filed: October 24, 2011
    Date of Patent: December 16, 2014
    Assignee: Massachusetts Institute of Technology
    Inventors: Edward Boyden, Jacob Bernstein, Christian Wentz, Giovanni Talei Franzesi, Michael Baratta, Brian Allen, Anthony Zorzos, Jorg Scholvin, Clifton Fonstad
  • Publication number: 20140164341
    Abstract: A method and apparatus for populating a contact in an address book on a mobile computing device. In some embodiments, the method includes receiving data associated with a first entity, processing the data received to extract contact information associated with the first entity, populating a user contact entry based on the extracted contact information, and storing the populated user contact in the address book.
    Type: Application
    Filed: December 11, 2012
    Publication date: June 12, 2014
    Applicant: VONAGE NETWORK LLC
    Inventors: MICHAEL BARATTA, TZAHI EFRATI
  • Publication number: 20120089205
    Abstract: In exemplary implementations of this invention, high-throughput screening of a mammalian brain is performed to locate neural circuit targets of interest. A variety of search patterns may be used for this neural screening, including (a) iterative subdivision, (b) serial search, and (c) combinatorial. To perform this neural screening, an array of optical fibers (or an array of waveguides) is inserted into the brain. Alternately, the array is positioned adjacent to the brain. Each fiber or waveguide in the array is coupled to a light source (LED or laser). The brain has been previously sensitized to light, using genetically encoded optical neural control reagents, which are delivered either using viruses or via transgenic means. In the screening, the array is used to optically perturb the brain. For example, the neurons of the brain may be activated by one color of light, and/or silenced by another color of light.
    Type: Application
    Filed: October 24, 2011
    Publication date: April 12, 2012
    Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Edward Boyden, Jacob Bernstein, Christian Wentz, Giovanni Talei Franzesi, Michael Baratta, Brian Allen, Anthony Zorzos, Jorg Scholvin, Clifton Fonstad